Rock Springs Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Rock Springs Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37M	Hold	45,500	–	–	0.08%	92
2025 Q4	$1.42M	Buy	+45,500	New	+$1.12M	0.07%	94
2016 Q3	–	Sell	-395,000	Closed	-$19.8M	–	139
2016 Q2	$19.8M	Hold	395,000	–	–	1.47%	20
2016 Q1	$21.1M	Buy	395,000 +15,700	+4%	+$921K	1.77%	14
2015 Q4	$24.9M	Buy	379,300 +54,300	+17%	+$3.36M	1.89%	14
2015 Q3	$18.4M	Buy	+325,000	New	+$21.1M	1.49%	18

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rock Springs Capital Management's TEVA Position: Q1 2026 in Review

Rock Springs Capital Management held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 45,500 shares worth $1.37M. The position accounts for 0.08% of the portfolio, ranked #92.

Rock Springs Capital Management first reported a position in TEVA in Q3 2015 and has held it in 6 quarters since. The position peaked at $24.9M in Q4 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Rock Springs Capital Management held 45,500 shares of Teva Pharmaceuticals worth $1.37M as of Q1 2026.
Rock Springs Capital Management left its Teva Pharmaceuticals share count unchanged in Q1 2026.
Teva Pharmaceuticals made up 0.08% of Rock Springs Capital Management's portfolio in Q1 2026, its #92 holding.
Rock Springs Capital Management first reported a position in Teva Pharmaceuticals in Q3 2015 and has held it in 6 quarters since.
Rock Springs Capital Management's Teva Pharmaceuticals position peaked at $24.9M in Q4 2015.
651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Rock Springs Capital Management's 13F filing for Q1 2026, filed 15 May 2026.